Voluntary retirement and portfolio selection: Dynamic programming approaches

Yong Hyun Shin

DOI: https://doi.org/10.1016/j.aml.2012.03.023

IF: 4.294

2012-07-01

Applied Mathematics Letters

Abstract:

What problem does this paper attempt to address?

Molecular Mechanisms and Clinical Applications of Mir-22 in Regulating Malignant Progression in Human Cancer (Review)

Jingyu Wang,Yuan Li,Meiman Ding,Honghe Zhang,Xiaoming Xu,Jinlong Tang

DOI: https://doi.org/10.3892/ijo.2016.3811

2016-01-01

International Journal of Oncology

Abstract:miRNAs (microRNAs) have been validated to play fateful roles in the occurrence and development of cancers by post-transcriptionally targeting 3′-untranslated regions of the downstream gene mRNAs to repress mRNA expression. Mounting investigations forcefully document that not only does miR-22 biologically impinge on the processes of senescence, energy supply, angiogenesis, EMT (epithelial-mesenchymal transition), proliferation, migration, invasion, metastasis and apoptosis, but also it genetically or epigenetically exerts dual (inhibitory/promoting cancer) effects in various cancers via CNAs (copy number alterations), SNPs (single nucleotide polymorphisms), methylation, acetylation and even more momentously hydroxymethylation. Additionally, miR-22 expression may fluctuate with cancer progression in the body fluids of cancer patients and miR-22 could amplify its inhibitory or promoting effects through partaking in positive or negative feedback loops and interplaying with many other related miRNAs in the cascade of events, making it possible for miR-22 to be a promising and complementary or even independent cancer biomarker in some cancers and engendering profound influences on the early diagnosis, therapeutics, supervising curative effects and prognosis.
Function of microRNA-145 and mechanisms underlying its role in malignant tumor diagnosis and treatment.

Dong Ye,Zhisen Shen,Shuihong Zhou

DOI: https://doi.org/10.2147/CMAR.S191696

2019-01-01

Cancer Management and Research

Abstract:miRNAs are single-stranded small RNAs that do not encode proteins. They can combine complementarily with the 3'-UTRs of target gene mRNA molecules to promote targeted mRNA degradation or inhibit mRNA translation, thereby regulating gene expression at the post-transcriptional level. MiRNAs participate in regulation of cell cycling, growth, apoptosis, differentiation, and stress responses. MiRNA-145 (miR-145) is a tumor suppressor that targets various tumor-specific genes and proteins, thereby influencing related signaling pathways. MiR-145 not only regulates tumor growth, invasion, and metastasis, but is also important for tumor angiogenesis and tumor stem cell proliferation. Here, we review the roles and mechanisms of miR-145 in the diagnosis and treatment of malignant tumors. Published data confirm that miR-145 expression in various tumors is significantly lower than that in normal tissues and that overexpression of miR-145 inhibits the growth of different tumor cells, significantly reduces the ability of tumors to spread, and improves sensitivity to chemotherapeutic drugs. We conclude that miR-145 is a potential marker for use in the early diagnosis and prognostic evaluation of patients with cancer, has a role as a tumor suppressor, and is a promising cancer treatment target candidate.
Function of Microrna-145 and Mechanisms Underlying Its Role in Malignant Tumor Diagnosis and Treatment

D. Ye,Zhisen Shen,Shuihong Zhou

DOI: https://doi.org/10.2147/cmar.s191696

2019-01-01

Cancer Management and Research

Abstract:miRNAs are single-stranded small RNAs that do not encode proteins. They can combine complementarily with the 3′-UTRs of target gene mRNA molecules to promote targeted mRNA degradation or inhibit mRNA translation, thereby regulating gene expression at the post-transcriptional level. MiRNAs participate in regulation of cell cycling, growth, apoptosis, differentiation, and stress responses. MiRNA-145 (miR-145) is a tumor suppressor that targets various tumor-specific genes and proteins, thereby influencing related signaling pathways. MiR-145 not only regulates tumor growth, invasion, and metastasis, but is also important for tumor angiogenesis and tumor stem cell proliferation. Here, we review the roles and mechanisms of miR-145 in the diagnosis and treatment of malignant tumors. Published data confirm that miR-145 expression in various tumors is significantly lower than that in normal tissues and that overexpression of miR-145 inhibits the growth of different tumor cells, significantly reduces the ability of tumors to spread, and improves sensitivity to chemotherapeutic drugs. We conclude that miR-145 is a potential marker for use in the early diagnosis and prognostic evaluation of patients with cancer, has a role as a tumor suppressor, and is a promising cancer treatment target candidate.
Melatonin secretion and age

D. Thomas,A. Miles

DOI: https://doi.org/10.1016/0006-3223(89)90187-X

IF: 12.81

1989-02-01

Biological Psychiatry

Abstract:
Aberrant regulation of miR-15b in human malignant tumors and its effects on the hallmarks of cancer

Ci Zhao,Guanyu Wang,Yuanyuan Zhu,Xiaobo Li,Feihu Yan,Chunhui Zhang,Xiaoyi Huang,Yanqiao Zhang

DOI: https://doi.org/10.1007/s13277-015-4269-2

2015-11-19

Tumor Biology

Abstract:MicroRNAs encoded by the miR-15b/16-2 cluster act as tumor suppressors. Aberrant regulation of miR-15b in human malignant tumors is reportedly involved in cancer development, contributing to cell death, reduced proliferation, angiogenesis and metastasis resistance, metabolism reprogramming, genome instability, and tumor-associated inflammation. In this review, we summarize the mechanisms involved in regulating miR-15b expression in mammalian tumors and discuss the effects of miR-15b dysregulation on the hallmarks of cancer and highlight its role as a potentially valuable target for future cancer therapeutic strategies.
The miR‐15a/16 gene cluster in human cancer: A systematic review

Ting Liu,Zhenru Xu,Daming Ou,Jing Liu,Ji Zhang

DOI: https://doi.org/10.1002/jcp.27342

2018-09-24

Journal of Cellular Physiology

Abstract:MicroRNAs (miRNAs) are an important class of endogenous small noncoding single-stranded RNAs that suppress the expression of their target genes through messenger RNA (mRNA) degradation to inhibit transcription and translation. MiRNAs play a crucial regulatory role in many biological processes including proliferation, metabolism, and cellular malignancy. miR-15a/16 is an important tumor suppressor gene cluster with a variety of factors that regulate its transcriptional activity. It has been discovered that a relative reduction of miR-15a/16 expression in various cancers is closely related to the occurrence and progression of tumors. miR-15a/16 takes part in a wide array of biological processes including tumor cell proliferation, apoptosis, invasion, and chemoresistance by binding to the 3'-untranslated region of its target gene's mRNA. In this review, we will examine the complex regulatory network of miR-15a/16 gene expression and its biological functions in human cancers to further elucidate the molecular mechanisms of its antitumor effects.

cell biology,physiology
miR-155 in cancer drug resistance and as target for miRNA-based therapeutics

Recep Bayraktar,Katrien Van Roosbroeck

DOI: https://doi.org/10.1007/s10555-017-9724-7

2017-12-27

Cancer and Metastasis Reviews

Abstract:Small non-coding microRNAs (miRNAs) are instrumental in physiological processes, such as proliferation, cell cycle, apoptosis, and differentiation, processes which are often disrupted in diseases like cancer. miR-155 is one of the best conserved and multifunctional miRNAs, which is mainly characterized by overexpression in multiple diseases including malignant tumors. Altered expression of miR-155 is found to be associated with various physiological and pathological processes, including hematopoietic lineage differentiation, immune response, inflammation, and tumorigenesis. Furthermore, miR-155 drives therapy resistance mechanisms in various tumor types. Therefore, miR-155-mediated signaling pathways became a potential target for the molecular treatment of cancer. In this review, we summarize the current findings of miR-155 in hematopoietic lineage differentiation, the immune response, inflammation, and cancer therapy resistance. Furthermore, we discuss the potential of miR-155-based therapeutic approaches for the treatment of cancer.

oncology
A Review on the Role of miR-149-5p in the Carcinogenesis

Soudeh Ghafouri-Fard,Tayyebeh Khoshbakht,Bashdar Mahmud Hussen,Sepideh Kadkhoda,Mohammad Taheri,Arash Tafrishinejad

DOI: https://doi.org/10.3390/ijms23010415

2021-12-30

Abstract:miR-149 is an miRNA with essential roles in carcinogenesis. This miRNA is encoded by the MIR149 gene on 2q37.3. The miR-149 hairpin produces miR-149-5p and miR-149-3p, which are the "guide" and the sister "passenger" strands, respectively. Deep sequencing experiments have shown higher prevalence of miR-149-5p compared with miR-149-3p. Notably, both oncogenic and tumor suppressive roles have been reported for miR-149-5p. In this review, we summarize the impact of miR-149-5p in the tumorigenesis and elaborate mechanisms of its involvement in this process in a variety of neoplastic conditions based on three lines of evidence, i.e., in vitro, in vivo and clinical settings.
miR-15/107 microRNA Gene Group: Characteristics and Functional Implications in Cancer

Chiara Turco,Sara Donzelli,Giulia Fontemaggi

DOI: https://doi.org/10.3389/fcell.2020.00427

IF: 5.5

2020-06-17

Frontiers in Cell and Developmental Biology

Abstract:The miR-15/107 group of microRNAs (miRNAs) encloses 10 annotated human members and is defined based on the presence of the sequence AGCAGC near the mature miRNAs' 5′ end. Members of the miR-15/107 group expressed in humans are highly evolutionarily conserved, and seven of these miRNAs are widespread in vertebrate species. Contrary to the majority of miRNAs, which recognize complementary sequences on the 3′UTR region, some members of the miR-15/107 group are peculiarly characterized by the ability to target the coding sequence (CDS) of their target mRNAs, inhibiting translation without strongly affecting their mRNA levels. There is compelling evidence that different members of the miR-15/107 group regulate overlapping lists of mRNA targets but also show target specificity. The ubiquitously expressed miR-15/107 gene group controls several human cellular pathways, such as proliferation, angiogenesis, and lipid metabolism, and might be altered in various diseases, such as neurodegenerative diseases and cancer. Intriguingly, despite sharing the same seed sequence, different members of this family of miRNAs may behave as oncomiRs or as tumor suppressor miRNAs in the context of cancer cells. This review discusses the regulation and functional contribution of the miR-15/107 group to the control of gene expression. Moreover, we particularly focus on the contribution of specific miR-15/107 group members as tumor suppressors in breast cancer, reviewing literature reporting their ability to function as major controllers of a variety of cell pathways and to act as powerful biomarkers in this disease.

cell biology,developmental biology
The role of miR-155 in urologic malignancies

Maolei Shen,Tao Chen,Xin Li,Shankun Zhao,Xinsheng Zhang,Liying Zheng,Biao Qian

DOI: https://doi.org/10.1016/j.biopha.2024.116412

IF: 7.419

2024-03-24

Biomedicine & Pharmacotherapy

Abstract:MicroRNAs (miRNAs) are a class of short non-coding RNAs that play a crucial role in regulating gene expression across multiple levels. They are involved in a wide range of physiological processes, including proliferation, differentiation, apoptosis, and cell cycle control. In recent years, miRNAs have emerged as pivotal regulatory molecules in the development and progression of tumors. Among these, miR-155 has garnered significant attention due to its high expression in various diseases, particularly urologic malignancies. Since an extensive corpus of studies having focused on the roles of miR-155 in various urologic malignancies, it is essential to summarize the current evidence on this topic through a comprehensive review. Altered miR-155 expression is related to various physiological and pathological processes, including immune response, inflammation, tumor development and treatment resistance. Notably, alterations in miR-155 expression have been observed in urologic malignancies as well. The up-regulation of miR-155 expression is commonly observed in urologic malignancies, contributing to their progression by targeting specific proteins and signaling pathways. This article provides a comprehensive review of the significant role played by miR-155 in the development of urologic malignancies. Furthermore, the potential of miR-155 as a biomarker and therapeutic target in urologic malignancies is also discussed.

pharmacology & pharmacy,medicine, research & experimental
MicroRNA-155 and its exosomal form: Small pieces in the gastrointestinal cancers puzzle

Jinbao Guo,Li Zhong,Mohammad Reza Momeni

DOI: https://doi.org/10.1007/s10565-024-09920-2

2024-09-16

Abstract:Gastrointestinal (GI) cancers are common cancers that are responsible for a large portion of global cancer fatalities. Due to this, there is a pressing need for innovative strategies to identify and treat GI cancers. MicroRNAs (miRNAs) are short ncRNAs that can be considered either cancer-causing or tumor-inhibiting molecules. MicroRNA-155, also known as miR-155, is a vital regulator in various cancer types. This miRNA has a carcinogenic role in a variety of gastrointestinal cancers, including pancreatic, colon, and gastric cancers. Since the abnormal production of miR-155 has been detected in various malignancies and has a correlation with increased mortality, it is a promising target for future therapeutic approaches. Moreover, exosomal miR-155 associated with tumors have significant functions in communicating between cells and establishing the microenvironment for cancer in GI cancers. Various types of genetic material, such as specifically miR-155 as well as proteins found in cancer-related exosomes, have the ability to be transmitted to other cells and have a function in the advancement of tumor. Therefore, it is critical to conduct a review that outlines the diverse functions of miR-155 in gastrointestinal malignancies. As a result, we present a current overview of the role of miR-155 in gastrointestinal cancers. Our research highlighted the role of miR-155 in GI cancers and covered critical issues in GI cancer such as pharmacologic inhibitors of miRNA-155, miRNA-155-assosiated circular RNAs, immune-related cells contain miRNA-155. Importantly, we discussed miRNA-155 in GI cancer resistance to chemotherapy, diagnosis and clinical trials. Furthermore, the function of miR-155 enclosed in exosomes that are released by cancer cells or tumor-associated macrophages is also covered.
Tumor-Suppressive and Oncogenic Roles of microRNA-149-5p in Human Cancers

Yang Shen,Nan Zhao,Nan Zhao,Xinyao Hu,Xiaoqin He,Yangtao Xu,Jiayu Chen,Wenliang Chen,Xin Liu,Zhuolin Zhou,Dedong Cao,Ximing Xu

DOI: https://doi.org/10.3390/ijms231810823

IF: 5.6

2022-09-17

International Journal of Molecular Sciences

Abstract:Malignant tumors are always a critical threat to human health, with complex pathogenesis, numerous causative factors, and poor prognosis. The features of cancers, such as gene mutations, epigenetic alterations, and the activation and inhibition of signaling pathways in the organism, play important roles in tumorigenesis and prognosis. MicroRNA (miRNA) enables the control of various molecular mechanisms and plays a variety of roles in human cancers, such as radiation sensitivity and tumor immunity, through the regulation of target genes. MiR-149-5p participates in the process and is closely related to lipogenesis, the migration of vascular endothelial cells, and the expression of stem-cell-related proteins. In recent years, its role in cancer has dramatically increased. In this review, we summarize the regular physiological roles of miRNAs, specifically miR-149-5p, in the organism and discuss the tumor-suppressive or oncogenic roles of miR-149-5p in different human cancers with respect to signaling pathways involved in regulation. Possible clinical applications of miR-149-5p in future targeted therapies and prognosis improvement in oncology are suggested.

biochemistry & molecular biology,chemistry, multidisciplinary
Molecular Mechanisms and Roles of MiR-136-5p in Human Cancer and Other Disorders

Xiaoling Chen,Ting Lu,Ying Zheng,Zhiyong Lin,Chaoqi Liu,Ding Yuan,Chengfu Yuan

DOI: https://doi.org/10.2174/0109298673283936240215110627

IF: 4.74

2024-04-27

Current Medicinal Chemistry

Abstract:Background: MiR-136-5p plays a vital function in regulating developmental processes as well as in the pathophysiology of diseases, with a notable record in tumor suppression. Methods: This article summarizes the latest findings on the physiological and pathophysiological processes of miR-136-5p in diseases. We searched for relevant studies and selected research articles from the last five years on PubMed with miR-136-5p as the keyword. Results: MiR-136-5p represents a class of microRNAs (miRNAs) that are involved in various human maladies, encompassing cancers, cardio-cerebrovascular disease, diabetes, inflammatory disease, tuberous sclerosis, idiopathic pulmonary fibrosis, and polycystic ovary syndrome. Altered expression of miR-136-5p in specific ailments results in downstream gene expression imbalance, influencing cellular behaviors, such as migration, proliferation, and invasion. Furthermore, miR-136-5p is implicated in five signaling pathways, where it is critical in the onset and advancement of a number of illnesses. Additionally, it has the potential to promote drug resistance to a variety of medications. Conclusion: The current review aims to elucidate the role of miR-136-5p in both cancer progression and non-cancerous disorders, emphasizing dysregulated signaling pathways. It also sheds light on the potential of this miRNA as a prognostic biomarker in cancer, offering valuable insights and directions for future research.

pharmacology & pharmacy,biochemistry & molecular biology,chemistry, medicinal
Role of microRNA-505 during tumor progression and metastasis

Amirhosein Maharati,Meysam Moghbeli

DOI: https://doi.org/10.1016/j.prp.2024.155344

IF: 3.309

2024-05-13

Pathology - Research and Practice

Abstract:Late diagnosis of cancer in advanced stages due to the lack of screening methods is considered as the main cause of poor prognosis and high mortality rate among these patients. Therefore, it is necessary to investigate the molecular tumor biology in order to introduce biomarkers that can be used in cancer screening programs and early diagnosis. MicroRNAs (miRNAs) have key roles in regulation of the cellular pathophysiological processes. Due to the high stability of miRNAs in body fluids, they are widely used as the non-invasive tumor markers. According to the numerous reports about miR-505 deregulation in a wide range of cancers, we investigated the role of miR-505 during tumor progression. It was shown that miR-505 mainly has the tumor suppressor functions through the regulation of signaling pathways, chromatin remodeling, and cellular metabolism. This review has an effective role in introducing miR-505 as a suitable marker for the early cancer diagnosis.

pathology
The Roles of microRNA miR-185 in Digestive Tract Cancers

Esmaeel Babaeenezhad,Fakhraddin Naghibalhossaini,Masoumeh Rajabibazl,Zohreh Jangravi,Forouzan Hadipour Moradi,Mohammad Davood Fattahi,Mostafa Moradi Sarabi,Soroosh Shahryarhesami,Jörg D. Hoheisel

DOI: https://doi.org/10.3390/ncrna8050067

2022-10-08

Non-Coding RNA

Abstract:Digestive tract cancers represent a serious public health issue. In recent years, evidence has accumulated that microRNA miR-185 is implicated in the pathogenesis of this group of highly malignant tumors. Its expression variations correlate with clinical features, such as tumor size, lymph node metastasis, tumor node metastatic stage, survival, recurrence and response to adjuvant therapy, and have diagnostic and prognostic potential. In this review, we compile, evaluate and discuss the current knowledge about the roles of miR-185 in digestive tract cancers. Interestingly, miR-185 is apparently involved in regulating both tumor suppressive and oncogenic processes. We look at downstream effects as well as upstream regulation. In addition, we discuss the utility of miR-185 for diagnosis and its potential concerning novel therapeutic approaches.
Functions and Underlying Mechanisms of Mir-650 in Human Cancers

Yuanshuai Su,Qiuxian Zheng,Lingxiao Zhu,Xinyu Gu,Juan Lü,Lanjuan Li

DOI: https://doi.org/10.1186/s12935-022-02551-9

IF: 6.429

2022-01-01

Cancer Cell International

Abstract:MicroRNAs (miRNAs) are one type of noncoding RNAs that interfere with mRNA translation to downregulate gene expression, which results in posttranscriptional gene silencing. Over the past two decades, miRNAs have been widely reported to impact the progression of malignant tumours by interfering with cancer initiation and progression; therefore, miRNAs represent potential new diagnostic and therapeutic tools. miR-650 is a newly identified miR, and increasing studies have demonstrated that miR-650 plays critical roles in cancer progression, such as mediating the Wnt signalling pathway/AXIN1 (axis inhibition protein 1) axis in hepatocellular carcinoma. Nevertheless, associations between the expression patterns and molecular mechanisms of miR-650 in cancer have not been comprehensively described. In this article, we review the existing evidence regarding the mechanisms by which miR-650 expression is altered and their relation to cancer. Moreover, the promising clinical application of miR-650 for diagnosis and treatment is highlighted.
MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF

Jianting Long,Chunlin Jiang,Baoxian Liu,Shi Fang,Ming Kuang

DOI: https://doi.org/10.1007/s13277-015-4427-6

2015-11-18

Tumor Biology

Abstract:We examined the expression pattern and functional roles of microRNA 15a-5p (miR-15a-5p) in human hepatocellular carcinoma (HCC). Possible miR-15a-5p aberrant expression in HCC cell lines or clinical HCC specimens was examined by quantitative real-time PCR (qRT-PCR). In HCC HepG2 and SNU-182 cells, miR-15a-5p was ectopically overexpressed by lentiviral transduction. Its effect on HCC proliferation, cancer division, and in vivo tumor growth were examined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, cell cycle assay, and tumorigenicity assay, respectively. The targeting of miR-15a-5p on its downstream gene, brain-derived neurotrophic factor (BDNF), was examined by dual-luciferase assay, qRT-PCR, and Western blot, respectively. BDNF was then overexpressed in HepG2 and SNU-182 cells to evaluate its selective effect on miR-15a-5p in HCC modulation. MiR-15a-5p is aberrantly downregulated in in vitro HCC cell lines and in vivo HCC clinical specimens. Ectopic overexpression of miR-15a-5p suppressed cancer proliferation, induced cell cycle arrest in HepG2 or SNU-182 cells in vitro, and inhibited HCC tumor growth in vivo. MiR-15a-5p selectively and negatively regulated BDNF at both gene and protein levels in HCC cells. Forced overexpression of BDNF effectively reversed the tumor suppressive functions of miR-15a-5p on HCC proliferation and cell division in vitro. Our study demonstrated that miR-15a-5p is a tumor suppressor in HCC and its regulation is through BDNF in HCC.
Renal selectivity properties towards endogenous albumin in minimal change nephropathy.

G. Ghiggeri,G. Candiano,F. Ginevri,R. Gusmano,M. Ciardi,F. Perfumo,G. Delfino,C. Cuniberti,C. Queirolo

DOI: https://doi.org/10.1038/KI.1987.173

IF: 19.6

1987-07-01

Kidney International

Abstract:
miR‐142‐3p/5p role in cancer: From epigenetic regulation to immunomodulation

Parisa Zareifar,Hani Moslem Ahmed,Pouya Ghaderi,Yalda Farahmand,Negin Rahnama,Romina Esbati,Ali Moradi,Omid Yazdani,Yasin Sadeghipour

DOI: https://doi.org/10.1002/cbf.3931

2024-01-31

Cell Biochemistry and Function

Abstract:MicroRNAs (miRNAs) play critical roles in cancer pathobiology, acting as regulators of gene expression and pivotal drivers of tumorigenesis. It is believed that miRNAs act through canonical mechanisms, involving the binding of mature miRNAs to target messenger RNAs (mRNAs) and subsequent repression of protein translation or degradation of target mRNAs. miR‐142‐3p/5p has been extensively studied and established as a key regulator in various malignancies. Recent discoveries have revealed miR‐142‐3p/5p serve as either oncogene or tumor suppressor in cancer. By targeting epigenetic factor and cancer‐related signaling pathway, miR‐142‐3p/5p can regulate wide range of downstream genes. The immune modulatory role of miR‐142‐3p/5p has been shown in various cancers, which provides significant insight into immunosuppression and tumor escape from the immune response. Exosomes with miR‐142‐3p/5p facilitate cell communication and can affect cancer cell behavior, offering potential therapeutic, and diagnosis applications in cancer therapy. In this review, for the first time, we comprehensively summarize the current knowledge regarding mentioned functions of miR‐142‐3p/5p in cancer pathobiology.

cell biology,biochemistry & molecular biology
A Review on the Role of miR-1246 in the Pathoetiology of Different Cancers

Soudeh Ghafouri-Fard,Tayyebeh Khoshbakht,Bashdar Mahmud Hussen,Mohammad Taheri,Mohammad Samadian

DOI: https://doi.org/10.3389/fmolb.2021.771835

IF: 6.113

2022-01-03

Frontiers in Molecular Biosciences

Abstract:miR-1246 is a microRNA firstly recognized through application of a high throughput sequencing technique in human embryonic stem cells. Subsequent studies have shown the role of this microRNA in the carcinogenesis. miR-1246 has been found to exert oncogenic roles in colorectal, breast, renal, oral, laryngeal, pancreatic and ovarian cancers as well as melanoma and glioma. In lung, cervical and liver cancers, studies have reported contradictory results regarding the role of miR-1246. miR-1246 has been reported to regulate activity of RAF/MEK/ERK, GSK3β, Wnt/β-catenin, JAK/STAT, PI3K/AKT, THBS2/MMP and NOTCH2 pathways. In addition to affecting cell cycle progression and proliferation, miR-1246 can influence stemness and resistance of cancer cells to therapeutics. In the current review, we describe the summary of in vitro and in vivo studies about the influence of miR-1246 in carcinogenesis in addition to studies that measured expression levels of miR-1246 in clinical samples.

biochemistry & molecular biology

Voluntary retirement and portfolio selection: Dynamic programming approaches

Molecular Mechanisms and Clinical Applications of Mir-22 in Regulating Malignant Progression in Human Cancer (Review)

Function of microRNA-145 and mechanisms underlying its role in malignant tumor diagnosis and treatment.

Function of Microrna-145 and Mechanisms Underlying Its Role in Malignant Tumor Diagnosis and Treatment

Melatonin secretion and age

Aberrant regulation of miR-15b in human malignant tumors and its effects on the hallmarks of cancer

The miR‐15a/16 gene cluster in human cancer: A systematic review

miR-155 in cancer drug resistance and as target for miRNA-based therapeutics

A Review on the Role of miR-149-5p in the Carcinogenesis

miR-15/107 microRNA Gene Group: Characteristics and Functional Implications in Cancer

The role of miR-155 in urologic malignancies

MicroRNA-155 and its exosomal form: Small pieces in the gastrointestinal cancers puzzle

Tumor-Suppressive and Oncogenic Roles of microRNA-149-5p in Human Cancers

Molecular Mechanisms and Roles of MiR-136-5p in Human Cancer and Other Disorders

Role of microRNA-505 during tumor progression and metastasis

The Roles of microRNA miR-185 in Digestive Tract Cancers

Functions and Underlying Mechanisms of Mir-650 in Human Cancers

MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF

Renal selectivity properties towards endogenous albumin in minimal change nephropathy.

miR‐142‐3p/5p role in cancer: From epigenetic regulation to immunomodulation

A Review on the Role of miR-1246 in the Pathoetiology of Different Cancers